Severe acetaminophen hepatotoxicity frequently leads to acute liver failure (ALF). We determined the incidence, risk factors, and outcomes of acetaminophen-induced ALF at 22 tertiary care centers in the United States. Detailed prospective data were gathered on 662 consecutive patients over a 6-year
Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study
โ Scribed by William J. Holubek; Susanne Kalman; Robert S. Hoffman
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 42 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
In addition to the hypothetical liver vulnerability of homozygous CCR5-โฌ32 patients, it seems that CCR5 de ficiency may increase the susceptibility to other diseases. Preliminary results from our laboratory also suggest that CCR5-deficient mice disclose higher susceptibility to experimental pancreatitis. 9 This may explain why CCR5-โฌ32 mutation represents only a small minority of the population in most parts of the world.
The recent observation of a hepatotoxic adverse event in patients treated with CCR5 inhibitors is consistent with our experimental observations. As pointed by S. Mauss and M. Puoti, HIV patients are frequently exposed to other hepatotoxic agents (virus, alcohol, drugs). The hypothetical vulnerability of patients with CCR5 deficiency must be kept in mind for the future use of CCR5 inhibitors.
๐ SIMILAR VOLUMES
and the Acute Liver Failure Study Group Acute liver failure (ALF) due to drug-induced liver injury (DILI), though uncommon, is a concern for both clinicians and patients. The Acute Liver Failure Study Group has prospectively collected cases of all forms of acute liver failure since 1998. We describe
Studies of acute liver failure from drugs have included cases mostly attributed to acetaminophen (APAP) but have reported limited data on other drugs. We used the United Network for Organ Sharing (UNOS) liver transplant database from 1990 to 2002 to identify recipients and estimate a U.S. population
Severe acetaminophen hepatotoxicity frequently leads to acute liver failure (ALF). We determined the incidence, risk factors, and outcomes of acetaminopheninduced ALF at 22 tertiary care centers in the United States. Detailed prospective data were gathered on 662 consecutive patients over a 6-year p
Despite extensive investigations, the cause of liver injury in 14% of patients with acute liver failure remains unknown (indeterminate). In a pilot study using a novel assay, highly specific acetaminophen-cysteine adducts were detected in 7 of 36 indeterminate patients (19%). To extend these observa